Catalyst Wire Dossier Catalyst Wire Dossier

Olpasiran

olpasiran · Amgen
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Olpasiran, covering 2023-08-23 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events [Phase 3]

See pricing